Gilmore ONeill

Gilmore ONeill is a highly accomplished medical professional with a strong background in neurology and public health. They pursued their education at prestigious institutions like Harvard Medical School, Harvard School of Public Health, and University College Dublin, obtaining degrees in M.Med.Sc Neurology, CITP, and MB, BCh, BAO respectively.

With a wealth of experience in the pharmaceutical industry, Gilmore ONeill has held significant leadership roles, notably serving as the Chief Medical Officer at Sarepta Therapeutics. Prior to this, they made valuable contributions at Biogen, where they held positions such as Senior Vice President for Late Stage Clinical Development, Senior Vice President for Drug Innovation Units, VP for Multiple Sclerosis Clinical Development, and Vice President for Experimental Neurology at BiogenIdec.